Di Molecular health gmbh

Circa la società

Since 2004, Molecular Health has stood for transforming big data into precise, actionable decisions for all stakeholders in healthcare. Their cloud-based Dataome® technology platform analyzes the molecular and clinical data of individual patients against the world’s medical, biological, and pharmacological knowledge, to drive more precise diagnostic, therapeutic, and drug safety decisions. Their products are used across the healthcare sector, as more precise ways of practicing medicine impact the treatment of patients and the development of effective drugs, requiring ever more complex levels of data interpretation. The company is financed by Dievini Hopp BioTech, an investment vehicle of former SAP CEO and founder Dietmar Hopp.